These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22398670)

  • 1. Edema index-guided disease management improves 6-month outcomes of patients with acute heart failure.
    Liu MH; Wang CH; Huang YY; Tung TH; Lee CM; Yang NI; Wang JS; Kuo LT; Cherng WJ
    Int Heart J; 2012; 53(1):11-7. PubMed ID: 22398670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure.
    Liu MH; Wang CH; Huang YY; Tung TH; Lee CM; Yang NI; Liu PC; Cherng WJ
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):299-306. PubMed ID: 22367574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioelectrical impedance analysis in the management of heart failure in adult patients with congenital heart disease.
    Sato M; Inai K; Shimizu M; Sugiyama H; Nakanishi T
    Congenit Heart Dis; 2019 Mar; 14(2):167-175. PubMed ID: 30351489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing lung fluid status using noninvasive bioelectrical impedance analysis in patients with acute heart failure: A pilot study.
    Lee S; Battumur B; Lee JE; Park SH; Choi YJ; Kang DO; Park EJ; Lee DI; Choi JY; Roh SY; Na JO; Choi CU; Kim JW; Rha SW; Park CG; Yong HS; Yang Z; Kim EJ
    Int J Cardiol; 2024 Aug; 409():132205. PubMed ID: 38795974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Bioelectrical Impedance for Predicting Clinical Outcomes in Outpatients With Heart Failure.
    Lyons KJ; Bischoff MK; Fonarow GC; Horwich TB
    Crit Pathw Cardiol; 2017 Mar; 16(1):32-36. PubMed ID: 28195941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
    Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
    J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
    Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
    JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of serum albumin level and clinical outcomes among heart failure patients receiving cardiac resynchronization therapy].
    Yang SW; Liu ZM; Mi JR; Liu SY; Ding LG; Chen KP; Hua W; Zhang S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):204-208. PubMed ID: 28316176
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial).
    Shochat MK; Shotan A; Blondheim DS; Kazatsker M; Dahan I; Asif A; Rozenman Y; Kleiner I; Weinstein JM; Frimerman A; Vasilenko L; Meisel SR
    J Card Fail; 2016 Sep; 22(9):713-22. PubMed ID: 27058408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ
    J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A telephone-delivered empowerment intervention with patients diagnosed with heart failure.
    Shearer NB; Cisar N; Greenberg EA
    Heart Lung; 2007; 36(3):159-69. PubMed ID: 17509423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive cardiac index monitoring during cardiopulmonary functional testing provides additional prognostic value in patients after acute heart failure.
    Lee MF; Chen WS; Fu TC; Liu MH; Wang JS; Hsu CC; Huang YY; Cherng WJ; Wang CH
    Int Heart J; 2012; 53(6):364-9. PubMed ID: 23258137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
    Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
    J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edema Index Predicts Mortality in Patients with Chronic Heart Failure: A Prospective, Observational Study.
    Sasmita BR; Zhao Y; Gong M; Luo S; Huang B
    Glob Heart; 2024; 19(1):5. PubMed ID: 38250704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
    Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
    J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioelectrical impedance analysis for perioperative water management in adult cardiovascular valve disease surgery.
    Watanabe T; Ishida N; Takaoka M; Tsujimoto K; Kondo K; Isoda R; Yukawa T; Tokunaga N; Ishida A; Fukazawa T; Morita I; Yoshida H; Kuinose M; Yamatsuji T
    Surg Today; 2021 Jun; 51(6):1061-1067. PubMed ID: 33259014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study.
    Miyoshi A; Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Okawa K; Kawamoto K; Morita H; Ito H
    J Cardiol; 2017 Nov; 70(5):425-431. PubMed ID: 28673507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.